Anti-inflammatory effects of locally applied enzyme-loaded ultradeformable vesicles on an acute cutaneous model

References

• Beers Jr RF, Sizer IW. A spectrophotometric method for measuring the breakdown of hydrogen peroxide by catalase. J Biol Chem 1952; 195: 133–140
   PubMedGoogle Scholar
• Brown MC, Martin GP, Jones SA, Akomeah FK. Dermal and transdermal drug delivery systems: Current and future prospects. Drug Del 2006; 13: 175–187
   PubMed Web of Science ®Google Scholar
• Burchardt ER, Müller-Peddinghaus R. Antiedematous effects of combination therapies with the leukotriene synthesis inhibitor BAYX 1005 in the arachidonic acid induced mouse ear inflammation test. Prostaglandins Leukotrienes Essential Fatty Acids 1997; 56: 301–306
   PubMedGoogle Scholar
• Cash CD. Are the reactive oxygen-derived species (ROS) interactive porperties of the many therapeutic drugs from various categories pertinent to their beneficial effects?. Gen Pharmac 1997; 28: 169–175
   PubMedGoogle Scholar
• Cevc G. Drug delivery across the skin. Exp Opin Invest Drugs 1997; 6: 1887–1937
   PubMedGoogle Scholar
• Cevc G, Blume G. Lipid vesicles penetrate into intact skin owing to the transdermal osmotic gradients and hydration force. Biochim Biophys Acta 1992; 1104: 226–232
   PubMed Web of Science ®Google Scholar
• Cevc G, Blume G. New, highly efficient formulation of diclofenac for the topical, transdermal administration in ultradeformable drug carriers, Transfersomes. Biochim Biophys Acta 2001; 1514: 191–205
   PubMed Web of Science ®Google Scholar
• Cevc G, Blume G, Schätzlein A. Transfersomes mediated transepidermal delivery improves the regio-specificity and biological activity of corticosteroids in vivo. J Contr Rel 1997; 45: 211–226
   Web of Science ®Google Scholar
• Cevc G, Blume G, Schätzlein A, Gebauer D. The skin: A pathway for systemic treatment with patches and lipid-based agent carriers. Adv Drug Deliv Rev 1996; 18: 349–378
   Web of Science ®Google Scholar
• Cevc G, Schätzlein A, Richardsen H. Ultradeformable lipid vesicles can penetrate the skin and other semi-permeable barriers intact. Evidence from double label CLSM experiments and direct size measurements. Biochim Biophys Acta 2002; 1564: 21–30
   PubMed Web of Science ®Google Scholar
• Cevc G, Vierl U. Spatial distribution of cutaneous microvasculature and local drug clearance after drug application on the skin. J Contr Rel 2007; 118: 18–26
   PubMed Web of Science ®Google Scholar
• Choi MJ, Maibach HI. Elastic vesicles as topical/transdermal drug delivery systems. Int J Cosmet Sci 2005; 27: 211–221
   PubMedGoogle Scholar
• Corvo ML, Boerman OC, Oyen WJ, Jorge JC, Cruz ME, Crommelin DJ, et al. Subcutaneous administration of superoxide dismutase entrapped in long circulating liposomes: In vivo fate and therapeutic activity in an inflammation model. Pharm Res 2000; 17: 600–606
   PubMed Web of Science ®Google Scholar
• Corvo ML, Boerman OC, Oyen WJG, Van Bloois L, Cruz MEM, Crommelin DJA, et al. Intravenous administration of superoxide dismutase entrapped in long circulating liposomes. II. In vivo fate in a rat model of adjuvant arthritis. Biochim Biophys Acta 1999; 1419: 325–334
   PubMed Web of Science ®Google Scholar
• Cuzzocrea S, Riley DP, Caputi AP, Salvemini D. Antioxidant therapy: A new pharmacological approach in shock, inflammation, and ischemia/reperfusion injury. Pharmacol Rev 2001; 53: 135–159
   PubMed Web of Science ®Google Scholar
• Edeas MA, Peltier E, Claise C, Khalfoun Y, Lindenbaum A. Immunocytochemical study of uptake of exogenous carrier-free copper-zinc superoxide dismutase by peripheral blood lymphocytes. Cell Mol Biol 1996; 42: 1137–1143
   PubMedGoogle Scholar
• El Maghraby GMM, Campbell M, Finnin BC. Mechanisms of action of novel skin penetration enhancers: Phospholipid versus skin lipid liposomes. Int J Pharm 2005; 305: 90–104
   PubMedGoogle Scholar
• Fang J-Y, Hwang T-L, Huang Y-L. Liposomes as vehicles for enhancing drug delivery via skin routes. Curr Nanosci 2006; 2: 55–70
   Web of Science ®Google Scholar
• Hamer RR, Tegeler JJ, Kurtz ES, Allen RC, Bailey SC, Elliott ME, et al. Dibenzoxepinone hydroxylamines and hydroxamic acids: Dual inhibitors of cyclooxygenase and 5-lipoxygenase with potent topical anti-inflammatory activity. J Med Chem 1996; 39: 246–252
   PubMedGoogle Scholar
• Heyneman CA, Lawless-Liday C, Wall GC. Oral versus topical NSAIDs in rheumatic diseases: A comparison. Drugs 2000; 60: 555–574
   PubMed Web of Science ®Google Scholar
• Horizoe T, Nagakura N, Chiba K, Shirota H, Shinoda M, Kobayashi N, et al. ER-34122, a novel dual 5-lipoxygenase/cyclooxygenase inhibitor with potent anti-inflammatory activity in an arachidonic acid-induced ear inflammation model. Inflamm Res 1998; 47: 375–383
   PubMedGoogle Scholar
• Jadot G, Vaille A, Maldonado J, Vanelle P. Clinical pharmacokinetics and delivery of bovine superoxide dismutase. Clin Pharmacokinet 1995; 28: 17–25
   PubMedGoogle Scholar
• Jubeh TT, Antler S, Haupt S, Barenholz Y, Rubinstein A. Local prevention of oxidative stress in the intestinal epithelium of the rat by adhesive liposomes of superoxide dismutase and tempamine. Molec Pharm 2005; 2: 2–11
   PubMed Web of Science ®Google Scholar
• Jubeh TT, Nadler-Milbauer M, Barenholz Y, Rubinstein A. Local treatment of experimental colitis in the rat by negatively charged liposomes of catalase, TMN and SOD. J Drug Target 2006; 14: 155–163
   PubMed Web of Science ®Google Scholar
• Kim B-J, Kim J-H, Heo M-Y, Kim H-P. Antioxidant and anti-inflammatory activities of the mung bean. Cosmetics Toiletries 1998; 113: 71–74
   Google Scholar
• Kimura K. Mechanisms of active oxygen species reduction by non-steroidal anti-inflammatory drugs. Int J Biochem Cell Biol 1997; 29: 437–446
   PubMedGoogle Scholar
• Lefaix J-L, Delanian S, Leplate J-J, Tricaud Y, Martin M, Nimrod A, et al. Successful treatment of radiation-induced fibrosis using Cu,Zn-SOD and Mn-SOD: An experimental study. Int J Radiat Oncol Biol Phys 1996; 35: 305–312
   PubMed Web of Science ®Google Scholar
• Lloret S, Moreno JJ. Effects of an anti-inflammatory peptide (antiflammin 2) on cell influx, eicosanoid biosynthesis and oedema formation by arachidonic acid and tetradecanoyl phorbol dermal application. Biochem Pharmacol 1995; 50: 347–353
   PubMed Web of Science ®Google Scholar
• Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 1951; 193: 265–275
   PubMed Web of Science ®Google Scholar
• Müller-Peddinghaus R, Kohlsdorfer C, Theisen-Popp P, Fruchtmann R, Perzborn E, Beckermann B, et al. BAY X1005, a new inhibitor of leukotriene synthesis: In vivo inflammation pharmacology and pharmacokinetics. J Pharmacol Exp Therap 1993; 267: 51–57
   PubMedGoogle Scholar
• Marques CM, Simões SI, Cruz ME, Cevc G, Martins MB. Formulation of catalase-loaded ultraflexible vesicles for transdermal delivery. Proceedings of the 8th Liposome Research Days Conference. 2002; 105
   Google Scholar
• Mizushima Y, Hoshi K, Yanagawa A, Takano K. Topical application of superoxide dismutase cream. Drugs Exp Clin Res 1991; 17: 127–131
   PubMedGoogle Scholar
• Muzykantov VR. Targeting of superoxide dismutase and catalase to vascular endothelium. J Contr Rel 2001; 71: 1–21
   PubMed Web of Science ®Google Scholar
• Prausnitz MR. Reversible skin permeabilization for transdermal delivery of macromolecules. Crit Rev Ther Drug Carrier Syst 1997; 14: 455–483
   PubMed Web of Science ®Google Scholar
• Puignero V, Queralt J. Effect of topically applied cyclosporin A on arachidonic acid (AA)- and tetradecanoylphorbol acetate (TPA)-induced dermal inflammation in mouse ear. Inflammation 1997; 21: 357–369
   PubMedGoogle Scholar
• Rother M, Lavins BJ, Kneer W, Lehnhardt K, Seidel EJ, Mazgareanu S. Efficacy and safety of epicutaneous ketoprofen in Transfersome (IDEA-033) versus oral celecoxib and placebo in osteoarthritis of the knee: Multicentre randomised controlled trial. Ann Rheum Dis 2007; 66: 1178–1183
   PubMed Web of Science ®Google Scholar
• Simões SI, Marques CM, Cruz MEM, Cevc G, Martins MB. Study of the tissue distribution of SOD-loaded transfersomes. Proceedings of the 8th Liposome Research Days Conference. 2002; 67
   Google Scholar
• Simões SI, Marques CM, Cruz MEM, Cevc G, Martins MBF. Novel carriers for antioxidant enzymes: Anti-inflammatory effects on arachidonic acid induced ear edema in mice. Barrier Function of Mammalian Skin. Bristol-Rhode IslandUSA 2003
   Google Scholar
• Simões SI, Martins MBF, Cruz MEM, Cevc G. Effects of transfersomal Cu/Zn-superoxide dismutase on arachidonic acid-induced ear edema in mice. Proceedings of Cosm’ing;. 1998; 266
   Google Scholar
• Simões SI, Richardsen HC, Martins MB, Cruz ME, Cevc G. Superoxide dismutase delivery through the narrow pores in skin models by flexible lipid aggregates. Proceedings of The III Spanish-Portuguese Conference on Controlled Drug Delivery. 1998; 49
   Google Scholar
• Simões SID. Preparation and characterization of enzyme-loaded Transfersomes. PhD thesis, 2005, Chapter 4
   Google Scholar
• Simões SI, Delgado TC, Lopes RM, Jesus S, Ferreira AA, Morais JA, et al. Developments in the rat adjuvant arthritis model and its use in therapeutic evaluation of novel non-invasive treatment by SOD in Transfersomes. J Contr Rel 2005; 103: 419–434
   PubMed Web of Science ®Google Scholar
• Simões SI, Marques CM, Cruz MEM, Cevc G, Martins MBF. The effect of cholate on solubilisation and permeability of simple and protein loaded phosphatidylcholine/sodium cholate mixed aggregates designed to mediate transdermal delivery of macromolecules. Eur J Pharm Biopharm 2004; 58: 509–519
   PubMed Web of Science ®Google Scholar
• Simões SI, Tapadas JM, Marques CM, Cruz MEM, Martins MBF, Cevc G. Permeabilisation and solubilisation of soybean phosphatidylcholine bilayer vesicles, as membrane models, by polysorbate, Tween 80. Eur J Pharmaceut Sci 2005; 26: 307–317
   PubMed Web of Science ®Google Scholar
• Szoka F, Olson F, Heath T, Vail W, Mayhew E, Papahadjopoulos D. Preparation of unilamellar liposomes of intermediate size (0.1–0.2 mumol) by a combination of reverse phase evaporation and extrusion through polycarbonate membranes. Biochim Biophys Acta 1980; 60: 559–571
   Google Scholar
• Thomson PD, Till GO, Woolliscroft JO, Smith DJ, Presad J. Superoxide dismutase prevents lipid peroxidation in burned patients. Burns 1990; 16: 406–408
   PubMed Web of Science ®Google Scholar
• Trenam CW, Dabbagh AJ, Morris CJ, Blake DR. Skin inflammation induced by reactive oxygen species (ROS): An in vivo model. Br J Dermatol 1991; 125: 325–329
   PubMed Web of Science ®Google Scholar
• Turrens JF, Crapo JD, Freeman BA. Protection against oxygen toxicity by intravenous injection of liposome-entrapped catalase and superoxide dismutase. J Clin Invest 1984; 73: 87–95
   PubMed Web of Science ®Google Scholar
• Vorauer-Uhl K, Furnschlief E, Wagner A, Ferko B, Katinger H. Topically applied liposome encapsulated superoxide dismutase reduces postburn wound size and edema formation. Eur J Pharm Sci 2001; 17: 63–67
   Google Scholar
• Walther FJ, David-Cu R, Lopez SL. Anti-oxidant-surfactant liposomes mitigate hyperoxic lung injury in premature rabbits. Am J Physiol 1995; 269: L613–L617
   PubMed Web of Science ®Google Scholar
• Way JC. Second-generation protein drugs: Children of the revolution. Drug Discov World 2002; 4: 62–68
   Google Scholar
• Yabe Y, Nishikava M, Tamada A, Takakura Y, Hashida M. Targeted delivery and improved therapeutic potential of catalase by chemical modification: Combination with superoxide dismutase derivatives. J Pharmacol Exp Therap 1999; 289: 1176–1184
   PubMed Web of Science ®Google Scholar
• Young JM, De Young LM. Cutaneous models of inflammation for the evaluation of topical and systemic pharmacological agents. Pharmacological methods in the control of inflammation, J Spector, N Back. Alan R Liss, New York 1989; 215–231
   Google Scholar